Prof.Dr. MAHMUT GÜMÜŞ

Transkript

1 Prof.Dr. MAHMUT GÜMÜŞ ÖZGEÇMİŞ DOSYASI KİŞİSEL BİLGİLER Doğum Yılı : Doğum Yeri : Sabit Telefon : Faks : E-Posta Adresi : Web Adresi : Posta Adresi : 1965 ANKARA T: F: mahmut.gumus@medeniyet.edu.tr mgumus@superonline.com EĞİTİM BİLGİLERİ Tıpta Yandal Uzmanlık, MARMARA ÜNİVERSİTESİ, Tıp Faültesi, Tıbbi Onkoloji BD, Tıpta Uzmanlık, Sağlık Bakanlığı, Dr.Lütfi Kırdar EAH, İç Hastalıkları Kliniği, Lisans, İSTANBUL ÜNİVERSİTESİ, İstanbul Tıp Fakültesi,, SERTİFİKALAR Yönetim Yeteneklerini Geliştirme, Partner Danışmanlık, 2011 AKADEMİK UNVANLAR/GÖREVLER Prof.Dr., İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ, Devam Ediyor Prof.Dr., BEZMİALEM VAKIF ÜNİVERSİTESİ, TIP FAKÜLTESİ, Prof.Dr., KIRKLARELİ ÜNİVERSİTESİ, SYO, Doç.Dr., MARMARA ÜNİVERSİTESİ, TIP FAKÜLTESİ, MESLEKİ VE İDARİ DENEYİM Üniversite Yönetim Kurulu Üyesi, İSTANBUL MEDENİYET ÜNİVERSİTESİ,, Devam Ediyor Etik Kurul Başkanı, BEZMİALEM VAKIF ÜNİVERSİTESİ Girişimsel Olmayan Araştırmalar Etik Kurulu,, Rektörlüğe Bağlı Komisyon Üyesi, BEZMİALEM VAKIF ÜNİVERSİTESİ Mevzuat Komisyonu Başkanı,, Üniversite Yönetim Kurulu Üyesi, BEZMİALEM VAKIF ÜNİVERSİTESİ,, Rektör Danışmanı, BEZMİALEM VAKIF ÜNİVERSİTESİ,, ARAŞTIRMA ALANLARI Onkoloji Sindirim Sistemi Kanserleri YÖNETİLEN TEZLER Tıpta Uzmanlık, M.Garip, "MEME KANSERİ NEDENİYLE OPERE OLANHASTALARDA MEME KORUYUCUCERRAHİ VEYA

2 RADİKAL MASTEKTOMİKARARINI ETKİLEYEN FAKTÖRLER VECERRAHİ TÜRÜNÜN HASTA ÜZERİNDEKİETKİLERİ", KARTAL EĞİTİM ve ARAŞTIRMA HASTANESİ AİLE HEKİMLİĞİ TIBBİ ONKOLOJİ, Ocak, SCI,SSCI,AHCI INDEXLERİNE GİREN DERGİLERDE YAYIMLANAN MAKALELER Bellmunt J., De Wit R., Vaughn D.J., Fradet Y., Lee J.-., Fong L., et al.,"pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma", NEW ENGLAND JOURNAL OF MEDİCİNE, vol.376, pp , 2017 Gümüş M., Bilici A., Odabas H., Ustaalioglu B., Kandemir N., Demirci U., et al.,"outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.", WORLD JOURNAL OF UROLOGY, vol.35, pp , 2017 Demirci A., Alkis N., Dane F., Durnalı A., Yazıcı Ö., Rzayev R., et al.,"retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study.", ASİA-PACİFİC JOURNAL OF CLİNİCAL ONCOLOGY, vol.-, 2017 Kaya S., Aktas B., Tanrikulu S.E., Akif O.M., Dede F., Kaya H., et al.,"changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.", JOURNAL OF BUON, vol.22, pp , 2017 Aksoy A., Odabas H., Kaya S., Bozkurt O., Degirmenci M., Topcu T., et al.,"hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.", SAUDİ MEDİCAL JOURNAL, vol.38, pp , 2017 Ercelep O., Topcu T., Bayoglu I., Ekinci A., Koca S., Kavgaci H., et al.,"retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.", TUMOR BIOLOGY, vol.37, pp , 2016 Yıldırım M., Kefeli U., Aydin D., Sener N., Gümüş M., "The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker.", TUMOR BIOLOGY, vol.37, pp , 2016 Aydin D., Sendur M., Kefeli U., Ustaalioglu B., Aydin O., Yildirim E., et al.,"evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma.", CLINICAL COLORECTAL CANCER, vol.-, 2016 Aydin D., Ali S.M., Kefeli U., Umut U.O., Tastekin D., Akyol M., et al.,"evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).", JOURNAL OF BUON, vol.21, pp , 2016 Ozcelik M., Korkmaz T., Odabas H., Gemici C., Ercelep O., Yuksel S., et al.,"comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients", TUMOR BIOLOGY, vol.37, pp , 2016 Aydin D., Sendur M., Kefeli U., Unal O., Tastekin D., Akyol M., et al.,"evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.", CLINICAL COLORECTAL CANCER, vol.-, 2016 Kaya S., Gümüş M., Gurbuz Y., Cabuk D., Acikgoz O., Temiz S., et al.,"the prognostic value of β-catenin and LEF-1 expression in patients with operable gastric carcinoma.", AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, vol.8, pp , 2016 Dinc N., Aydın K., Odabas H., Ercelep O., Tufan G., Seker M., et al.,"pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer.", ONCOLOGY RESEARCH AND TREATMENT, vol.39, pp.130-4, 2016 Ozcelik M., Seker M., Eraslan E., Koca S., Yazilitas D., Ercelep O., et al.,"evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology", TUMOR BIOLOGY, vol.37, pp , 2016 Ozcelik M., Odabas H., Ercelep O., Yuksel S., Mert A.G., Aydin D., et al.,"the efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.18, pp , 2016 Bilici A., Ozturk T., Turkmen E., Odabas H., Cihan S., Selcukbiricik F., et al.,"treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.", WORLD JOURNAL OF UROLOGY, vol.33, pp , 2015 Gunes-Bayir A., Kiziltan H., Sentürk N., Mayadagli A., Gümüş M., "A Pilot Study of Self-Reported Physical Activity and Eating Habits in Turkish Cancer Patients Under Chemotherapy.", NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, vol.67, pp , 2015 Bilici A., Sonkaya A., Ercan S., Ustaalioglu B., Seker M., Aliustaoglu M., et al.,"the changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors?", TUMOR BIOLOGY, vol.36, pp.823-8, 2015 Kafadar D., Ince N., Akcakaya A., Gümüş M., "Evaluation of Managerial Needs for Palliative Care Centers: Perspectives of Medical Directors.", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.16, pp , 2015

3 Benekli M., Altundag K., Dumanli E., Isikdogan A., Karaoglu A., Tekin S.B., et al.,"association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.", JOURNAL OF CLINICAL ONCOLOGY, vol.33, 2015 Odabas H., Ulas A., Aydın K., Inanc M., Aksoy A., Yazilitas D., et al.,"is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology.", TUMOR BIOLOGY, vol.36, pp , 2015 Mayadagli A., Karabulut G.S., Bilici A., Fatih O.A., Kocak M., Ozkan A., et al.,"prognostic significance of protein kinase B/Akt pathway in patients with non-small cell lung cancer.", JOURNAL OF BUON, vol.19, pp , 2014 Bilici A., Inanc M., Ulas A., Akman T., Seker M., Babacan N., et al.,"clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp , 2014 Yalcin S., Gümüş M., Kilickap S., Alkis N., Ilhan M., Oksuzoglu B., et al.,"end-of-study results of Turkish gastric cancer patients from the global REGATE study", JOURNAL OF BUON, vol.19, pp , 2014 Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al.,"treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology", WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.18, pp , 2014 Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al.,"treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology", WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.18, pp , 2014 Turan N., Benekli M., Dane F., Unal O., Kara H., Koca D., et al.,"adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.", THORACIC CANCER, vol.5, pp , 2014 Oven U.B., Bilici A., Yilmaz B., Aliustaoglu M., Seker M., Vardar F., et al.,"important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey.", BREAST CARE, vol.9, pp.123-7, 2014 Gumusay O., Coskun U., Akman T., Ekinci A.S., Kocar M., Erceleb O.B., et al.,"predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.140, pp , 2014 Korkmaz T., Seber S., Yavuzer D., Gümüş M., Turhal N.S., "Primary renal carcinoid: Treatment and prognosis", CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol.87, pp , 2013 Ustaalioglu B.B.O., Ulas A., Esbah O., Turan N., Bilici A., Demirci U., et al.,"large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey", THORACIC CANCER, vol.4, pp , 2013 Ustaalioglu B.B.O., Bilici A., Ercan S., Seker M., Orcun A., Gümüş M., "The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer", MEDICAL ONCOLOGY, vol.30, 2013 Berk V., Kaplan M.A., Tonyali O., Buyukberber S., Balakan O., Ozkan M., et al.,"efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp , 2013 Tonyali O., Coskun U., Sener N., Inanc M., Akman T., Ulas A., et al.,"prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab", ONKOLOGIE, vol.36, pp , 2013 Kefeli U., Benekli M., Sevinc A., Yildiz R., Kaplan M.A., Ciltas A., et al.,"efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience", ONCOLOGY LETTERS, vol.6, pp , 2013 Kefeli U., Buyukberber S., Akyol M., Yildiz R., Kaplan M.A., Ciltas A., et al.,"efficacy of Sunitinib in Turkish Patients with Gastrointestinal Stromal Tumors; Retrospective Multicenter Experience", HEPATO-GASTROENTEROLOGY, vol.60, pp , 2013 Kaplan M.A., Isikdogan A., Gümüş M., Arslan U.Y., Geredeli C., Ozdemir N., et al.,"childhood, Adolescents, and Young Adults (<= 25 y) Colorectal Cancer: Study of Anatolian Society of Medical Oncology", JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, vol.35, pp.83-89, 2013 Bilici A., Salman T., Ustaalioglu B.B.O., Unek T., Seker M., Aliustaoglu M., et al.,"the prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy", JOURNAL OF SURGICAL RESEARCH, vol.180, pp.e1-e9, 2013 Yetisyigit T., Arpaci E., Seber E.S., Kucukoner M., Kos F.T., Sonmez O.U., et al.,"salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp , 2013 Alici S., Buyukberber S., Alkis N., Benekli M., Ozkan M., Bilici A., et al.,"low-dose Docetaxel/Cisplatin - Leucovorin

4 and 46 Hour Infusional Fluorouracil in Metastatic Gastric Carcinoma", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp , 2013 Uygun K., Bilici A., Kaya S., Ustaalioglu B.B.O., Yildiz R., Temiz S., et al.,"xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two- Institutions", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp , 2013 Ustaalioglu B.B.O., Unal O.U., Turan N., Bilici A., Kaya S., Eren T., et al.,"prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp , 2013 Cetin B., Benekli M., Dane F., Boruban C., Gümüş M., Oksuzoglu B., et al.,"lapatinib plus Capecitabine for HER2- Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience", BREAST CARE, vol.8, pp.67-70, 2013 Seker M., Sevinc A., Yildiz R., Cihan S., Kaplan M.A., Gokdurnali A., et al.,"prognostic Factors in Gastrointestinal Stromal Tumors: Multicenter Experience of 333 Cases from Turkey", HEPATO-GASTROENTEROLOGY, vol.60, pp , 2013 Korkmaz T., Seber S., Kefeli U., Sari E., Canhoroz M., Oven B., et al.,"comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.15, pp , 2013 Ustaalioglu B.O., Bilici A., Kefeli U., Seker M., Oncel M., Gezen C., et al.,"the Importance of Multifocal/Multicentric Tumor on the Disease-Free Survival of Breast Cancer Patients Single Center Experience", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.35, pp , 2012 Inal A., Ciltas A., Yildiz R., Berk V., Kos F.T., Dane F., et al.,"long Term Survivors with Metastatic Pancreatic Cancer Treated with Gemcitabine Alone or Plus Cisplatin: a Retrospective Analysis of an Anatolian Society of Medical Oncology Multicenter Study", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.13, pp , 2012 Gümüş M., Davidson N., Bauknecht T., Soldatenkova V., Benhadji K.A., "Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study", CURRENT MEDICAL RESEARCH AND OPINION, vol.28, pp , 2012 Arslan U.Y., Oksuzoglu B., Ozdemir N., Aksoy S., Alkis N., Gok A., et al.,"outcome of non-metastatic male breast cancer: 118 patients", MEDICAL ONCOLOGY, vol.29, pp , 2012 Bilici A., Ustaalioglu B.B.O., Yavuzer D., Seker M., Mayadagli A., Gümüş M., "Prognostic Significance of High Phosphatase of Regenerating Liver-3 Expression in Patients with Gastric Cancer Who Underwent Curative Gastrectomy", DIGESTIVE DISEASES AND SCIENCES, vol.57, pp , 2012 Ustaalioglu B.O., Bilici A., Ercan S., Orcun A., Seker M., Ozkan A., et al.,"serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.14, pp , 2012 Inal A., Kos F.T., Algin E., Yildiz R., Dikiltas M., Unek I.T., et al.,"gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study", NEOPLASMA, vol.59, pp , 2012 Kefeli U., Yildirim M.E., Aydin D., Madenci O.C., Yasar N., Sener N., et al.,"netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment", BIOMARKERS, vol.17, pp , 2012 Tonyali O., Coskun U., Sener N., Inanc M., Akman T., Oksuzoglu B., et al.,"nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.138, pp , 2012 Ustaalioglu B.B.O., Bilici A., Barisik N.O., Aliustaoglu M., Vardar F.A., Yilmaz B.E., et al.,"clinical importance of phosphatase of regenerating liver-3 expression in breast cancer", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.14, pp , 2012 Bilici A., Seker M., Oven Ustaalioglu B.B., Hallac Keser S., Cinaral F., Gümüş M., "Gallbladder metastasis secondary to gastric cancer as a first site of recurrence presented with acute cholecystitis: Case report and literature review", TURKISH JOURNAL OF GASTROENTEROLOGY, vol.23, pp , 2012 Kaya A.O., Coskun U., Ozkan M., Sevinc A., Yilmaz A.U., Gümüş M., et al.,"paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy", ONKOLOGIE, vol.35, pp , 2012 Eser M., Kement M., Balin S., Coskun C., Kefeli U., Gümüş M., et al.,"is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer", WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012 Kaya A.O., Coskun U., Gümüş M., Dane F., Ozkan M., Isikdogan A., et al.,"the efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens", JOURNAL OF

5 CHEMOTHERAPY, vol.24, pp , 2012 Mayadagli A., Kocak M., Demir O., Gul S.K., Ozkan A., Parlak C., et al.,"elective bladder preservation with multimodality treatment for bladder cancer", JOURNAL OF BUON, vol.17, pp , 2012 Inal A., Kos F.T., Algin E., Yildiz R., Berk V., Unek I.T., et al.,"prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study", JOURNAL OF BUON, vol.17, pp , 2012 Gezen C., Kement M., Altuntas Y.E., Okkabaz N., Seker M., Vural S., et al.,"results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors", WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012 Altinbas M., Kalender M.E., Oven B., Sevinc A., Karaca H., Kaplan M.A., et al.,"weekly Topotecan for Recurrent Small Cell Lung Cancer - a Retrospective Anatolian Medical Oncology Group Study", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.13, pp , 2012 Bilici A., Ustaalioglu B.B.O., Ercan S., Seker M., Yilmaz B.E., Orcun A., et al.,"the prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer", TUMOR BIOLOGY, vol.33, pp , 2012 Ozkan M., Berk V., Kaplan M.A., Benekli M., Coskun U., Bilici A., et al.,"gemcitabine and Cisplatin Combination Chemotherapy in Triple Negative Metastatic Breast Cancer Previously Treated with a Taxane/Anthracycline Chemotherapy; Multicenter Experience", NEOPLASMA, vol.59, pp.38-42, 2012 Bilici A., Yapici H.S., Ercan S., Seker M., Ustaalioglu B.B.O., Salman T., et al.,"the prevalence and significance of autoantibodies in patients with non-hodgkin's lymphoma: are they correlated with clinicopathological features?", JOURNAL OF BUON, vol.17, pp , 2012 Bilici A., Dane F., Seker M., Ustaalioglu B.B.O., Aliustaoglu M., Temiz S., et al.,"is Subdivision of pt2 Tumors Superior to Lymph Node Metastasis for Predicting Survival of Patients with Gastric Cancer? Review of 224 Patients from Four Centers", DIGESTIVE DISEASES AND SCIENCES, vol.56, pp , 2011 Alkis N., Demirci U., Benekli M., Yilmaz U., Isikdogan A., Sevinc A., et al.,"mitomycin-c in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure", JOURNAL OF BUON, vol.16, pp.80-83, 2011 Barisik N.O., Keser S.H., Gul A.E., Sensu S., Kandemir N.O., Küçük H.F., et al.,"the value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast", MEDICAL ONCOLOGY, vol.28, pp , 2011 Kefeli U., Kaya S., Ustaalioglu B.O., Bilici A., Kefeli A.U., Yildirim M.E., et al.,"prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience", MEDICAL ONCOLOGY, vol.28, pp , 2011 Kefeli U., Bilici A., Ustaalioglu B.B.O., Kefeli A.U., Yildirim M.E., Seker M., et al.,"a case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.283, pp , 2011 Ustaalioglu B.B.O., Seker M., Bilici A., Canpolat N., Yildirim E., Kefeli U., et al.,"the role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma", MEDICAL ONCOLOGY, vol.28, pp , 2011 Bilici A., Ustaalioglu B.B.O., Ercan S., Orcun A., Seker M., Salepçi T., et al.,"is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?", CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.68, pp , 2011 Seker M., Bilici A., Ustaalioglu B.O., Yilmaz B., Ozturk B., Unal A., et al.,"clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.284, pp , 2011 Basaran G., Turhal N.S., Cabuk D., Yurt N., Yurtseven G., Gümüş M., et al.,"weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey", MEDICAL ONCOLOGY, vol.28, pp , 2011 Sevinc A., Seker M., Bilici A., Ozdemir N.Y., Yildiz R., Ustaalioglu B.O., et al.,"co-existence of Gastrointestinal Stromal Tumors with Other Primary Neoplasms", HEPATO-GASTROENTEROLOGY, vol.58, pp , 2011 Sonmez B., Seker M., Bilici A., Erkal F.Y., Ustaalioglu B.B.O., Gümüş M., et al.,"is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients with breast cancer?", JOURNAL OF BUON, vol.16, pp , 2011 Bilici A., Ustaalioglu B.B.O., Seker M., Kefeli U., Canpolat N., Tekinsoy B., et al.,"the role of F-18-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.38, pp.64-73, 2011 Mayadagli A., Aksu A., Goksel F., Gocen E., Karahacioglu E., Gümüş M., et al.,"determination OF PARAMETERS AFFECTING THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE IN CANCER PATIENTS AND DETECTION OF

6 PREVALENCE OF USE", AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, vol.8, pp , 2011 Seker M., Bilici A., Guler D.O., Ustaalioglu B.B., Gozu H., Erkal F.Y., et al.,"tissue and Serum Adiponectin Levels in Patients with Gastric Cancer: Are there any Correlations between Adiponectin Levels and Histopathological Variables?", HEPATO-GASTROENTEROLOGY, vol.58, pp , 2011 Ustaalioglu B.B.O., Bilici A., Kefeli U., Seker M., Salepci T., Unal O., et al.,"a retrospective analysis of women's chances to become pregnant after completion of chemotherapy: a single center experience", JOURNAL OF BUON, vol.16, pp , 2011 Bilici A., Seker M., Ustaalioglu B.B.O., Canpolat N., Salepçi T., Gümüş M., "Pulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: Report of First Case and F-18 FDG PET/CT Images", JOURNAL OF KOREAN MEDICAL SCIENCE, vol.26, pp , 2011 Dane F., Ozturk M.A., Gümüş M., Guven A., Aliustaoglu M., Cabuk D., et al.,"efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study", JOURNAL OF BUON, vol.16, pp , 2011 Gezen C., Altuntas Y.E., Kement M., Okkabaz N., Bilici A., Vural S., et al.,"laparoscopic Abdominoperineal Resections for Mid or Low Rectal Adenocarcinomas: A Retrospective, Comparative Study", SURGICAL LAPAROSCOPY ENDOSCOPY TECHNIQUES, vol.21, pp , 2011 Seker M., Ozdemir B., Bilici A., Ustaalioglu B.B., Sönmez B., Yilmaz B.E., et al.,"bilateral Conjunctival MALT Lymphoma Mimicking Chronic Conjunctivitis", ONKOLOGIE, vol.33, pp , 2010 Ustaalioglu B.B.O., Bilici A., Kefeli U., Seker M., Yildirim E., Salepçi T., et al.,"does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences", ONCOLOGY, vol.79, pp , 2010 Bilici A., Ustaalioglu B.B.O., Gümüş M., Seker M., Yilmaz B., Kefeli U., et al.,"is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?", ONKOLOGIE, vol.33, pp , 2010 Karagoz B., Bilgi O., Gümüş M., Erikci A.A., Sayan O., Turken O., et al.,"cd8+cd28-cells and CD4+CD25+regulatory T cells in the peripheral blood of advanced stage lung cancer patients", MEDICAL ONCOLOGY, vol.27, pp.29-33, 2010 Aliustaoglu M., Bilici A., Ustaalioglu B.B.O., Konya V., Gucun M., Seker M., et al.,"the effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment", MEDICAL ONCOLOGY, vol.27, pp , 2010 Yumuk P.F., Kefeli U., Ceyhan B., Dane F., Eroglu B.T., Gümüş M., et al.,"pulmonary toxicity in patients receiving docetaxel chemotherapy", MEDICAL ONCOLOGY, vol.27, pp , 2010 Bilici A., Bilici A., Ustaalioglu B.B.O., Seker M., Canpolat N., Gümüş M., "F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome", CLINICAL NUCLEAR MEDICINE, vol.35, pp , 2010 Bilici A., Seker M., Ustaalioglu B.B.O., Kefeli U., Yildirim E., Yavuzer D., et al.,"prognostic Significance of Perineural Invasion in Patients with Gastric Cancer Who Underwent Curative Resection", ANNALS OF SURGICAL ONCOLOGY, vol.17, pp , 2010 Bilici A., Seker M., Ustaalioglu B.B.O., Yilmaz B., Doventas A., Salepçi T., et al.,"determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer", MEDICAL ONCOLOGY, vol.27, pp , 2010 Ustaalioglu B.B.O., Gümüş M., Bilici A., Seker M., Ustaalioglu R., Kefeli U., et al.,"is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experience", JOURNAL OF BUON, vol.15, pp , 2010 Bilici A., Ustaalioglu B.B.O., Seker M., Canpolat N., Tekinsoy B., Salepçi T., et al.,"clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.37, pp , 2010 Seker M., Ustaalioglu B.B.O., Bilici A., Yildirim M.E., Kefeli U., Barisik N.O., et al.,"eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma", LEUKEMIA RESEARCH, vol.34, pp.e160-e163, 2010 Ustaalioglu B.B.O., Gümüş M., Unal A., Cayir K., Sever O., Bilici A., et al.,"malignancies Diagnosed During Pregnancy and Treated With Chemotherapy or Other Modalities (Review of 27 Cases) Multicenter Experiences", INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.20, pp , 2010 Aliustaoglu M., Bilici A., Gümüş M., Colak A.T., Baloglu G., Irmak R., et al.,"preoperative serum leptin levels in patients with breast cancer", MEDICAL ONCOLOGY, vol.27, pp , 2010 Ustaalioglu B.B.O., Gümüş M., Bilici A., Seker M., Dane F., Salepçi T., et al.,"neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience", MEDICAL ONCOLOGY, vol.27, pp , 2010

7 Kaya A.O., Buyukberber S., Dane F., Isikdogan A., Ustaalioglu B.O., Coskun U., et al.,"cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer", TUMORI, vol.96, pp , 2010 Aliustaoglu M., Bilici A., Seker M., Dane F., Gocun M., Konya V., et al.,"the Association of Pre-treatment Peripheral Blood Markers with Survival in Patients with Pancreatic Cancer", HEPATO-GASTROENTEROLOGY, vol.57, pp , 2010 Sezen O.S., Eraslan G., Coskuner T., Yavuzer D., Bilici A., Bilge S., et al.,"endometrial Adenocarcinoma Metastasis to Nasal Skin", JOURNAL OF OTOLARYNGOLOGY-HEAD SURGERY, vol.39, pp.e8-e11, 2010 Barisik N.O., Bozkurt S., Gümüş M., Kaygusuz I., Karadayi N., Bas E., et al.,"expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study", DIAGNOSTIC PATHOLOGY, vol.5, 2010 Gümüş M., Ustaalioglu B.O., Garip M., Kiziltan E., Bilici A., Seker M., et al.,"factors that Affect Patients' Decision- Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients", BREAST CARE, vol.5, pp , 2010 Seker M., Bilici A., Sönmez B., Ustaalioglu B.B.O., Gümüş M., Gozu H., et al.,"the association of serum adiponectin levels with histopathological variables in gastric cancer patients", MEDICAL ONCOLOGY, vol.27, pp , 2010 Bilici A., Salepçi T., Dane F., Gümüş M., Ustaalioglu B.B.O., Seker M., et al.,"neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.282, pp , 2010 Salepçi T., Seker M., Uyarel H., Gümüş M., Bilici A., Ustaalioglu B.B.O., et al.,"5-fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels", MEDICAL ONCOLOGY, vol.27, pp , 2010 Ustaalioglu B.B.O., Bilici A., Seker M., Canpolat N., Ozdemir N., Salepçi T., et al.,"primary non-hodgkin lymphoma of cervix successfully treated with rituximab: Positron emission tomography images before and after therapy: A case report", LEUKEMIA RESEARCH, vol.34, pp.e108-e110, 2010 Bilici A., Uygun K., Seker M., Ustaalioglu B.B.O., Aliustaoglu M., Temiz S., et al.,"the Effect of Tumor Size on Overall Survival in Patients with pt3 Gastric Cancer: Experiences from 3 Centers", ONKOLOGIE, vol.33, pp , 2010 Salman T., Seker M., Bilici A., Ustaalioglu B.B., Gümüş M., Yaylaci M., "Lung cancer presenting with extreme leukocytosis", JOURNAL OF BUON, vol.15, pp , 2010 Oven B.B.U., Bilici A., Seker M., Salepci T., Keser S., Gümüş M., "Renal cell carcinoma with pulmonary metastasis misdiagnosed as other primary malignant tumor", JOURNAL OF BUON, vol.14, pp , 2009 Seker M., Ustaalioglu B.B., Bilici A., Ozseker N.I., Aksu A., Gümüş M., "Acute renal failure and multiple extranodal involvement in a patient with diffuse large B cell lymphoma", JOURNAL OF BUON, vol.14, pp , 2009 Kocak M., Ozkan A., Mayadagli A., Parlak C., Bilici A., Bilici A., et al.,"induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: A single-institution review of two different regimens", CLINICAL LUNG CANCER, vol.10, pp , 2009 Alici S., Coskun U., Alkış N., Sevinc A., Dane F., Gümüş M., et al.,"vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.10, pp , 2009 Karaoglu A., Arslan U.Y., Ozkan M., Kalender M.E., Alici S., Coskun U., et al.,"efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.10, pp.63-66, 2009 Ustaalioglu B.B.O., Bilici A., Seker M., Salman T., Gümüş M., Barisik N.O., et al.,"metastasis of Lobular Breast Carcinoma to the Uterus in a Patient under Anastrozole Therapy", ONKOLOGIE, vol.32, pp , 2009 Salepci T., Seker M., Kurnaz E., Guler D., Bilici A., Dane F., et al.,"conjunctival malt lymphoma successfully treated with single agent rituximab therapy", LEUKEMIA RESEARCH, vol.33, pp.1-1, 2009 Demirhan R., Mayadagli A., Parlak C., Kocak M., Ozkan A., Gümüş M., "Our resection outcome in lung cancer: Evaluation of 45 consequential patients", JOURNAL OF CLINICAL ONCOLOGY, vol.26, 2008 Kaya A.O., Coskun U., Unlu M., Akdemir U.O., Ozdemir N.Y., Zengin N., et al.,"whole Body 18F-FDG PET/CT Imaging in the Detection of Primary Tumours in Patients with a Metastatic Carcinoma of Unknown Origin", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.9, pp , 2008 Bilgi O., Karagoz B., Turken O., Kandemir E.G., Ozturk A., Gümüş M., et al.,"peripheral blood gamma-delta T cells in advanced-stage cancer patients", ADVANCES IN THERAPY, vol.25, pp , 2008 Koldas M., Gümüş M., Seker M., Seval H., Karaoglu H., Dane F., et al.,"thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer", CLINICAL LUNG CANCER, vol.9, pp , 2008 Kocak M., Mayadagli A., Ozkan A., Parlak C., Demir O., Marti A., et al.,"outcome of metastatic non-small cell lung carcinoma patients receiving docetaxel-cisplatin combination chemotherapy: single institution experience", JOURNAL OF BUON, vol.12, pp , 2007

8 Sakar B., Gümüş M., Basaran M., Argon A., Ustuner Z., Ustaoglu M.A., et al.,"xelox followed by XELIRI or the reverse sequence in advanced colorectal cancer", ONCOLOGY, vol.73, pp , 2007 Gümüş M., Yumuk P.F., Salepci T., Aliustaoglu M., Dane F., Ekenel M., et al.,"hpv DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples", JOURNAL OF EXPERIMENTAL CANCER RESEARCH, vol.25, pp , 2006 Gümüş M., Yumuk P., Atalay G., Aliustaoglu M., Macunluoglu B., Dane F., et al.,"what is the optimal number of lymph nodes to be dissected in colorectal cancer surgery?", TUMORI, vol.91, pp , 2005 Yumuk P., Abacioglu U., Demir G., Cabuk D., Dane F., Gümüş M., et al.,"does the incidence of anal canal cancers differ in Moslem societies?", INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol.20, pp.76-76, 2005 Yumuk P., Turhal N., Gümüş M., Hatabay N., Turken O., Ozkan A., et al.,"results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer", BMC CANCER, vol.5, 2005 Turhal N., Dane F., Dede F., Gümüş M., Yumuk P., Cakalagaoglu F., et al.,"99m-tc-mdp-scintimammography in the evaluation of breast masses or tumor angiogenesis", ANTICANCER RESEARCH, vol.24, pp , 2004 Aliustaoglu M., Yumuk P., Gümüş M., Ekenel M., Bolukbas F., Bolukbas C., et al.,"d-dimer - Can it be a marker for malignant gastric lesions?", ACTA ONCOLOGICA, vol.43, pp , 2004 Yumuk P., Aydin S., Dane F., Gümüş M., Ekenel M., Aliustaoglu M., et al.,"the absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients", INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol.19, pp , 2004 Bolukbas F., Kilic H., Bolukbas C., Gümüş M., Horoz M., Turhal N., et al.,"serum leptin concentration and advanced gastrointestinal cancers: a case controlled study", BMC CANCER, vol.4, 2004 Sakar B., Karagol H., Gümüş M., Basaran M., Kaytan E., Argon A., et al.,"timing of death from tumor recurrence after curative gastrectomy for gastric cancer", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.27, pp , 2004 Yumuk P., Gümüş M., Ekenel M., Basaran G., Aliustaoglu M., Topal A., et al.,"attitude toward genetic testing for cancer risk in Istanbul", GENETIC TESTING, vol.8, pp , 2004 Bolukbas F., Bolukbas C., Horoz M., Gümüş M., Erdogan M., Zeyrek F., et al.,"child-pugh classification dependent alterations in serum leptin levels among cirrhotic patients: a case controlled study", BMC GASTROENTEROLOGY, vol.4, 2004 Yumuk P., Abacioglu U., Caglar H., Gümüş M., Sengoz M., Turhal N., "Outcome of rectal and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in marmara university hospital", JOURNAL OF CHEMOTHERAPY, vol.15, pp , 2003 Turhal N.S., Aliustaoglu M., Gurses A., Gümüş M., Atalay G., Karamanoglu A., et al.,"neoplastic diseases prevalence in a turkish university hospital", JOURNAL OF BUON, vol.8, pp.45-48, 2003 Turk-Boru U., Kocer A., Alp R., Gumus M., Gümüş M., "Status epilepticus in a case of Wilson's disease during D- pencillamine treatment", SWISS MEDICAL WEEKLY, vol.133, pp , 2003 Turhal N., Efe B., Gümüş M., Aliustaoglu M., Karamanoglu A., Sengoz M., "Patient satisfaction in the outpatients' chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey.", BMC CANCER, vol.2, pp.30-30, 2002 Turhal N.S., Gümüş M., Atalay G., Aliustaoglu M., Kabakas F., Karamanoglu A., et al.,"outpatient cancer care in a Turkish University hospital", JOURNAL OF BUON, vol.7, pp , 2002 DİĞER DERGİLERDE YAYIMLANAN MAKALELER Yanik A., Gümüş M., "The Tendency for Social Phobic Anxiety and Avoidance in University Students ", International Refereed Journal of Humanities and Academic Sciences, vol.19, pp.25-49, 2017 Ozmen V., Dagoglu N., Dede I., Akcakaya A., Kerem M., Goksel F., et al.,"turkish Ministry of Health, 2nd Turkish Medical General Assembly Clinical Oncology Study Group Report", JOURNAL OF BREAST HEALTH, vol.12, pp.9-17, 2016 Kefeli U., Ustaalioglu B.B.O., Yilmaz B., Aydin D., Sener N., Aliustaoglu M., et al.,"non-small Cell Lung Cancer in Women: A Distinct Entity?", Gazi Medical Journal, cilt.25, ss.92-96, 2014 Gül Ş.K., Mayadağli A., Gümüş M., "Akciğer Kanserli Geriatrik Hastalarda Tedavi YaklaşımıTreatment Approach for Lung Cancer of Geriatric Patients", J Kartal TR, cilt.25, ss , 2014 Aydin K., Gümüş M., "İleri Evre Gastroenteropankreatik Nöroendokrin Tümörlerin Tedavisinde Sunitinib'in Yeri", Turkiye Klinikleri Journal of Medical Oncology Special Topics, cilt.6, ss.57-60, 2013 Bilici A., Ustaalioglu B.B.O., Seker M., Gümüş M., Ünal O., "Clinicopathological features in patients with rare ovarian cancers", Türk Onkoloji Dergisi, cilt.27, ss , 2012

9 Ustaalioglu B.B.O., Bilici A., Seker M., Salepci T., Ustaalioğlu R., Cömert S., et al.,"the Relationship between Prognostic Factors andoverall Survival in Small Cell Lung Cancer Patients:a Single Centre Experience", Türk Toraks Dergisi, cilt.13, ss.60-64, 2012 Mayadağli A., Ekici K., Kökten Ş., Gümüş M., "Memenin Primer Skuamöz Hücreli Karsinomu:Olgu Sunumu ve Literatürün Gözden Geçirilmesi", Okmeydanı Tıp Dergisi, cilt.28, ss , 2012 Ekici K., Mayadagli A., Korkmaz T., Barisik N., Gümüş M., "Sarcomatoid carcinoma of the small intestine: a case report and review of the literature", Case Study and Case Report, vol.2, pp.74-80, 2012 Gümüş M., "Epidemiology and Etiology in Gastric Cancer", Turkiye Klinikleri Journal of Medical Oncology Special Topics Issue, cilt.5, ss.1-5, 2012 Ustaalioğlu B.B., Ustaalioğlu R., Bilici A., Doğusoy I., Barişik N.Ö., Gümüş M., "GÖĞÜS DUVARINA METASTAZ YAPAN VE CERRAHİ UYGULANAN RENAL PELVİS KARSİNOMA OLGUSU", Acta Oncologica Turcica, cilt.44, ss.36-41, 2011 Şeker M., Mengi A., Bilici A., Ustaalioğlu B.B., Kefeli U., Özşeker N.I., et al.,"evaluation of Hodgkin lymphoma cases and determination of prognostic factors/hodgkin lenfoma olgularinin retrospektif degerlendirilmesive prognostik faktorlerin saptanmasi", Turkish Journal of Oncology, cilt.26, ss , 2011 Gümüş M., "Antijen Temelli Aşılar", Turkiye Klinikleri J Med Oncol-Special Topics, cilt.3, ss.77-82, 2010 Bilici A., Seker M., Ustaalioglu B.B.O., Dane F., Aliustaoglu M., Erkol B., et al.,"lenf Nodu Negatif Mide Kanserli Hastalarda Sağkalım Üzerine EtkiliPrognostik Faktörlerin Değerlendirilmesi: Üç Merkez Deneyimi", Türk Onkoloji Dergisi, cilt.25, ss , 2010 Bilici A., Seker M., Ustaalioglu B.B.O., Salman T., Salepci T., Yavuzer D., et al.,"a Case of Recurrent Breast Cancer Diagnosed vvithisolated Ovarian Metastasis Under Anastrazole Therapy", Acta Oncologica Turcica, cilt.43, ss.42-45, 2010 Aliustaoglu M., Ustaalioglu B.B.O., Bilici A., Konya V., Gücün M., Seker M., et al.,"is the Complete Blood Count ParametersPredict Prognosis Before Treatment inmetastatic Gastric Cancer Patients?", Acta Oncologica Turcica, cilt.43, ss.13-18, 2010 Bilici A., Gümüş M., "Kapesitabin: Kolorektal Kanserlerde Kullanımı", Remisyon, cilt.10, ss.11-16, 2010 Ustaalioglu B.B.O., Bilici A., Seker M., Salepci T., Yildirim E., Kefeli U., et al.,"inflamatuvar Meme Kanseri Serimiz:Tek Merkez Deneyimi", Acta Oncologica Turcica, cilt.42, ss.93-99, 2009 Ustaalioglu B., Seker M., Bilici A., Erkol B., Kefeli U., Yildirim E., et al.,"nadir BİR NAZOLAKRİMAL HEMANJİYOPERİSTOMOLGUSU", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.19, ss.93-96, 2008 Demirhan R., Öz K., Çağan P., Dabak R., Mayadağli A., Gümüş M., "Mediastinal Dev Schwannoma", Akciğer, cilt.13, ss.95-98, 2007 Demirhan R., Mayadağli A., Sancakli İ., Özdemir N., Gümüş M., Parlak C., et al.,"akciğer KANSERLERİNDE REZEKSİYON SONUÇLARIMIZ:ARDIŞIK 45 HASTANIN DEĞERLENDİRİLMESİ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.17, ss.82-88, 2006 Karaoğlu H., Gümüş M., Sargin H., Koç Y., Güler Ş., Colak A.T., et al.,"hodgkin DIŞI LENFOMALI HASTALARıN KLiNiK ÖZELLiKLERiNiN VETEDAVi SONUÇLARININ DEGERLENDiRiLMESi ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.15, ss.8-10, 2004 Yumuk F., İyikesici S., Gümüş M., Aliustaoglu M., Dane F., Basaran G., et al.,"lokal leri ve Metastatik Küçük Hücreli D fl Akci er Kanseri Hastalar n n De erlendirilmesimarmara Üniversitesi Deneyimi", Türk Onkoloji Dergisi, cilt.19, ss , 2004 Basaran G., Ekenel M., Demirkalem P., Çakır T., Güllüoğlu B., Gümüş M., et al.,"evre I (T1N0M0) Meme Kanseri: Patolojik Özellikler ve Klinik Sonuçlar", Türk Onkoloji Dergisi, cilt.19, ss.53-57, 2004 Yıldız G., Sargin M., Sargin H., Gümüş M., Yayla A., "İmidazolin Reseptör Agonisti Rilmenidinin, Metabolik Sendrom X Olgularında Klinik, Metabolik ve Endokrin Parametrelere Etkisi.", Diabet Bilimi, cilt.1, ss.71-76, 2003 Ramazanoğlu D.T., Gümüş M., Koç Y., Şeker M., Sargin H., Tekçe M., et al.,"akut MYOKARD İNFARKTÜSÜ GEÇİREN ERKEK HASTALARDASERUM ÖSTRADİOL, TESTOSTERON VE NOREPİNEFRİN DÜZEYLERİ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.14, ss , 2003 Sever Ö.N., Gümüş M., Sargin H., Koç Y., Salepçi T., Yayla A., "MALİGN MEZOTELYOMA VAKALARINDA YÜKSEK DOZ METOTREKSATUYGULAMASININ ETKİNLİĞİ", Kartal E itim ve Araflt rma Hastanesi T p Dergisi, cilt.14, ss.20-22, 2003 Koç Y., Sargin H., Gemici C., Bolukbas F., Gümüş M., Tekçe M., et al.,"pankreas KARS NOMLU OLGULARIN DE ERLEND R LMES ", Kartal E itim ve Araflt rma Hastanesi T p Dergisi, cilt.14, ss , 2003 Karamanoglu A., Yumuk P.F., Gümüş M., Ekenel M., Aliustaoglu M., Selimen D., et al.,"port Needles: Do They Need to be Removed as Frequently in Infusional Chemotherapy?", Journal of Infusion Nursing, vol.26, pp , 2003 Erbay İ., Gümüş M., Sargin H., Fenercioğlu S., Sargin M., Seker M., et al.,"akut Myokard İnfarktüsünde Mikroalbuminüri ve Trombolitik Tedavinin Mikroalbuminüri Düzeylerine Etkisi", Şişli Etfal

10 Hastanesi Tıp Bülteni, cilt.36, ss.43-48, 2002 Biriz N., Gümüş M., Sargın M., Emre B., Koç Y., Aliustaoglu M., et al.,"diyabetik HASTALARDA KARACiGER YAGLANMASI VEy-GLUTAMiL TRANSPEPTiDAZ DÜZEYLERi ", Kartal Eğitim ve Araştırma Tıp Dergisi, cilt.12, ss.1-4, 2001 Türk Ü.B., Sargin H., Alp R., Sargin M., Gümüş M., Tekçe M., et al.,"ağrılı Diabetik Polinöropatide Vigabatrine Kullanımı", Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.34, ss.8-12, 2001 Fenercioğlu S., Gümüş M., Erbay İ., Sargin H., Sargin M., Aliustaoglu M., et al.,"akut MYOKARD İNFARKTÜSÜNDE AKUT FAZ REAKTANLARINDAKİDEGİşİM VE TROMBOLİTİK TEDAVİNİN BU DEGİşİME ETKİsİ ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.11, ss , 2000 Gümüş M., Urutürk O., Sargin M., Akin A., Koç Y., Aliustaoğlu M., et al.,"diyabet Süresi, HbA1c Düzeyleri ve Retinopati", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.11, ss , 2000 Koç Y., Gümüş M., Sargin M., Kavakli B., Yayla A., "ANTİHİPERTANSİF TEDAVİDE DOKSAZOsİN, AMLODİpİN VE RAMİpRiLİN KAN LİPID PROFİLİ VE KAN GLUKOZ DÜZEYİNE ETKİLERİNİN KARŞILAŞTIRILMASI ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.11, ss , 2000 Aliustaoğlu M., Gümüş M., Gökçel A., Özer T., Bican M., Özdil K., et al.,"kronik BÖBREK YETMEZLİGİNDE HEMODİYALİZİN ATRİALNATRİüRETİK PEPTİD DÜZEYLERİNE ETKİsİ ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.10, ss , 1999 Gümüş M., Kavaklı B., Aktaş S., Sarğin M., Aliustaoglu M., Özdil K., et al.,"anjiotensin II RESEPTÖR BLOKAJININ Tİp II DİABETESMELLİTUS'LU HASTALARDA KAN LİpİD DÜZEYLERİNE ETKİSi' ", KARTAL EĞİTİM ve ARAŞTIRMA KLİNİKLERİ, cilt.10, ss , 1999 Kavakli B., Sarğin M., Gümüş M., "DİABETES MELLİTUS'UN AKUT METABOLİKKOMPLİKASYONLARI - III:LAKTİK ASİDOZ ", Kartal Eğitim ve Araştırma Klinikleri, cilt.9, ss , 1998 Yıldız G., Kavaklı B., Gümüş M., Küçük H.F., Salepçi T., Sargın M., et al.,"bir İNSÜLİNOMA OLGUSU", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.1-4, ss , 1998 Kavakli B., Sargin M., Gümüş M., "DİABETES MELLİTUS'UN AKUT METABOLİK KOMPLİKASYONLARI - I :DİABETİK KETOASİDOZ ", Kartal Eğitim ve Araştırma Klinikleri, cilt.9, ss , 1998 Kavakli B., Sargin M., Gümüş M., "DiABETES MELLiTUS'UN AKUT METABOLiKKOMPLiKASYONLARI - II:HiPERGLiSEMiK HiPEROZMOLAR NONKETOTiK KOMA ", Kartal Eğitim Araştırma Klinikleri, cilt.9, ss , 1998 Dolapcioğlu C., Kavakli B., Tuncer K., Kiliç D., Aktunç E., Gümüş M., et al.,"cushing SENDROMU İLE SEYREDENBİR SÜRRENAL KARSİNOM OLGUSU ", KARTAL EĞİTİM vearaştirma KLİNİKLERİ, cilt.8, ss , 1997 Kavakli B., Kiliç D., Gümüş M., "TIP II DİABETTE BETA STİMÜLAN ORAL ANTİDİABETİKDROGLAR VE KULLANIM ENDİKASYONLARI ", Kartal Eğitim ve Araştırma Klinikleri, cilt.8, ss , 1997 KİTAP VEYA KİTAPLARDA BÖLÜMLER Gümüş M., "Jinekolojik Tümörler", Jinekolojik Tümörler, Aydıner A, Aslay I, Berkman S., Ed., Nobel Yayın Dağıtım, İstanbul, ss.1-309, 2016 HAKEMLİ KONGRE/SEMPOZYUM BİLDİRİ KİTAPLARINDA YER ALAN YAYINLAR Yumuk R., Turhal N., Ahiskali R., Gümüş M., Hatabay N., Turken O., et al.,"p53 Her2/neu as prognostic factors in advanced non-small cell lung cancer (NSCLC) treated with paclitaxel", World Lung Congress, KANADA, -, vol.49, pp.s152-s152 Kilickap S., Gümüş M., Uncu D., Ozkan M., Cicin I., Elkiran T.E., et al.,"outcomes of Turkish National Breast Cancer Registry.", ASCO 2017, CHICAGO, ABD, 30 Mayıs - 3 Haziran 2017, vol.35, pp.--- Gümüş M., Geredeli C., Ucar M., Kaya S., Demir H., Unal O.U., et al.,"egfr-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.", ASCO 2017, CHICAGO, ABD, 30 Mayıs - 3 Haziran 2017, vol.35, pp.--- Cicin I., Gümüş M., Uncu D., Ozkan M., Kilickap S., Elkiran T.E., et al.,"characteristics of Turkish colorectal cancer patients and bevacizumab preference.", ASCO 2017, CHICAGO, ABD, 30 Mayıs - 3 Haziran 2017, vol.35, pp.--- Bilici A., Gümüş M., Malhan S., Oksuz E., Oksuzoglu B., Yalcm S., "ECONOMIC BURDEN OF GASTRIC CANCER IN TURKEY", ISPOR 20th Annual European Congress, GLASGOW, INGILTERE, 6-6 Kasım 2017, vol.20, pp.a429-a429 Ciltas A., Karaca M., Uncu D., Ozkan M., Aliustaoglu M., Tekin S.B., et al.,"effect of body mass index in gastric cancer patients: Analysis of Turkish national gastric cancer registry", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2015, vol.33, pp.1-1 Gümüş M., Dane F., Karabulut B., Uygun K., Aydin K., Orhan B., et al.,"results of observational study to determine K- ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2015, vol.33, pp.1-1

11 Kaplan M.A., Urakci Z., Gümüş M., Arslan U.Y., Geredeli C., Ozdemir N., et al.,"what are the differences between young (25 years) and adults (> 25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2015, vol.33, pp.1-1 Benekli M., Altundag K., Dumanli E., Isikdogan A., Karaoglu A., Tekin S.B., et al.,"association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2015, vol.33, pp.1-1 Mutlu H.H., Mutlu H.H., Selek S., Mayadagli A., Turk H.M., Seker M., et al.,"metacognitive processes in cancer patients", ECCO-ESMO Congress, VİYANA, AVUSTURYA, Ekim 2015, vol.51, pp.s218-s218 Celik I., Mandel N.M., Gokmen E., Unal O.U., Sevinc A., Coskun H.S., et al.,"clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey", ASCO Annual Meeting, CHICAGO, ABD, 28 Mayıs - 5 Haziran 2015, vol.33, pp.1-1 Kilickap S., Altundag K., Dumanli E., Gümüş M., Uslu R., Ozyilkan O., et al.,"geographic variations of clinical characteristics in breast cancer: Analysis of Turkish National Breast Cancer Registry.", ASCO Annual Meeting, CHICAGO, ABD, 1-7 Haziran 2015, vol.33, pp.1-1 Akgün Z., Güral Z., Süt P., Seker M., Mayadagli A., Turk H.M., et al.,"lokal İLERİ PANKREAS KANSERİ TEDAVİSİNDE KAPESİTABİN BAZLI KEMOTERAPİ İLE HİPERFRAKSİYONE RADYOTERAPİNİNGÜVENİLİRLİĞİ-PİLOT ÇALIŞMA", 21.Ulusal Kanser Kongresi, ANTALYA, TÜRKIYE, Nisan 2015, ss Altundag K., Dumanli E., Aliustaoglu M., Uncu D., Ozkan M., Cicin I., et al.,"turkish National Breast Cancer Registry.", ASCO Annual Meeting, CHICAGO, ABD, 1-7 Haziran 2015, vol.33, pp.1-1 Yuksel S., Kodaz H., Yildiz I., Odabasi H., Ocak A., Bayoglu I.V., et al.,"frequency of EGFR Mutation in Nsclc and Its Relationship with Clinicopathological Features: A Multicenter Asmo Trial", WORLD LUNG CONGRESS, DENVER, ABD, 1-5 Kasım 2015, vol.10, pp.s586-s586 Ercelep O., Ekinci A.S., Bayoglu I.V., Uzunoglu S., Ulas A., Bozkurt O., et al.,"treatment and prognosis in mucosal. melanoma: An Anatolian Society of Medical Oncology Study.", ASCO Annual Meeting, CHICAGO, ABD, 2-7 Haziran 2014, vol.32, pp.1-1 Coskun U., Gümüş M., Uncu D., Ozkan M., Cicin I., Altundag K., et al.,"turkish Breast Cancer Registry: A multicenter epidemiologic study", ASCO Annual Meeting, CHICAGO, ABD, 2-7 Haziran 2014, vol.32, pp.1-1 Sendur M.A., Aksoy S., Uncu D., Demir H., Yuksel S., Ekinci A.S., et al.,"efficacy OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER", ESMO Congress, MADRID, ISPANYA, 26 Eylül - 30 Haziran 2014, vol.25, pp.1-1 Ozcelik M., Balvan Ercelep O., Guven Mert A., Yuksel S., Ozdemir P., Surmeli H., et al.,"three DIFFERENT CHEMOTHERAPY COMBINATIONS WITH CONCURRENT THORACIC RADIATION FOR PATIENTS WITH STAGE III NON- SMALL CELL LUNG CANCER", ESMO Congress, MADRİD, ISPANYA, Eylül 2014, vol.25, pp.1-1 Sevinc A., Seker M., Yildiz R., Cihan S., Kaplan M.A., Dane F., et al.,"the clinical and pathologic characteristics of 400 gastrointestinal stroinal tumor patients from Turkey: The final results of the Turkish Anatolian Society of Medical Oncology Multicenter Registery", ASCO Annual Meeting, CHICAGO, ABD, 3-8 Haziran 2014, vol.32, pp.1-1 Coskun U., Gunaydin Y., Ulas A., Balakan O., Inanc M., Inal A., et al.,"non-small CELL LUNG CANCER IN YOUNG PATIENTS: CLINICOPATHOLOGICAL FEATURES", WORLD LUNG CANCER CONGRESS, SYDNEY, AVUSTRALYA, Ekim 2013, vol.8, pp.s696-s696 Gümüş M., Dane F., Karabulut B., Uygun K., Orhan B., Aydin K., et al.,"interim results of observational study to determine K-ras mutation rates in patients with metastatic colorectal cancer in Turkey (TURKRAS study)", ECCO- ESMO Congress, AMSTERDAM, HOLLANDA, 27 Eylül - 1 Ekim 2013, vol.49, pp.s571-s571 Bilici A., Selcukbiricik F., Ustaalioglu B.B.O., Tural D., Seker M., Gümüş M., et al.,"prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer.", ASCO Annual Meeting, CHICAGO, ABD, 3-8 Haziran 2013, vol.31, pp.1-1 Yildiz R., Buyukberber S., Koca D., Korai L., Ciltas A., Unal O.U., et al.,"the efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.", ASCO Annual Meeting, CHICAGO, ABD, 3-8 Haziran 2013, vol.31, pp.1-1 Gümüş M., Yasar N., Kayahan S., Yuksel S., Balvan O., Mert A.G., et al.,"the relationship between collapsin response mediator protein-1 (CRMP 1) expression and histopathogic parameters and survival in patient with gastric cancer.", ASCO Annual Meeting, CHICAGO, ABD, 1-7 Haziran 2013, vol.31, pp.1-1 Bilici A., Selcukbiricik F., Ustaalioglu B.B., Seker M., Dane F., Aliustaoglu M., et al.,"the evaluation of factors predicting recurrence and prognosis for patients with node-negative gastric cancer after curative resection", ECCO- ESMO Congress, AMSTERDAM, HOLLANDA, 27 Eylül - 1 Ekim 2013, vol.49, pp.s588-s588 Seker M., Gümüş M., Barisik N.O., Dane F., Bozkurt S.U., Bilici A., et al.,"the prognostic impact of survivin and REG1A in diffuse large B-cell lymphoma", ECCO-ESMO Congress, AMSTERDAM, HOLLANDA, 27 Eylül - 1 Ekim 2013, vol.49,